CASM - CAS Medical Systems, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.96
-0.05 (-2.49%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.01
Open2.01
Bid1.00 x 3100
Ask2.04 x 800
Day's Range1.74 - 2.02
52 Week Range0.59 - 2.70
Volume199,396
Avg. Volume186,757
Market Cap54.45M
Beta0.15
PE Ratio (TTM)N/A
EPS (TTM)-0.12
Earnings DateNov 7, 2018 - Nov 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Trade prices are not sourced from all markets
  • Investopedia18 days ago

    Penny Stocks to Watch for September 2018

    Junior miners turned lower in sympathy with declining gold and silver contracts, while small biotech and medical diagnostic stocks picked up the slack, underpinned by sector funds probing new highs. September has a mixed reputation when it comes to small speculative plays, suggesting that traders focus their attention on penny stocks exhibiting the highest relative strength while avoiding falling knives that may face tax selling pressure in the fourth quarter. Low-priced energy stocks look like wild cards in this equation, with crude oil coming off lows while rising Middle East tensions add to sector buying power.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of CASM earnings conference call or presentation 2-Aug-18 2:00pm GMT

    Q2 2018 CAS Medical Systems Inc Earnings Call

  • Zacks Small Cap Researchlast month

    CASM: FORE-SIGHT Momentum Continues, Moving PT to $4.50/share

    The FORE-SIGHT business, particularly as it relates to the U.S. market, continues to impress. The U.S. installed base expanded by 25% yoy during the first half of 2018 and domestic sensor sales have now set new record highs for three consecutive quarters. U.S. FORE-SIGHT revenue grew by an average of 20% yoy over the last three quarters (including 20% in Q2).

  • GlobeNewswire2 months ago

    CASMED Reports Second Quarter 2018 Financial Results

    FORE-SIGHT ® sales growth, expands gross margin, narrows operating loss. Conference Call Begins at 10:00 a.m. Eastern Time Today. BRANFORD, Conn., Aug. 02, 2018-- CAS Medical Systems, Inc., a leader in ...

  • ACCESSWIRE2 months ago

    CAS Medical Systems, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 2, 2018 / CAS Medical Systems, Inc. (NASDAQ: CASM ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 2, 2018 at 10:00 AM Eastern ...

  • Investopedia2 months ago

    Penny Stocks to Watch for August 2018

    Penny stock pickers booked modest returns in these tough conditions, while trend followers and dart throwers took losses. The July penny stock list generated mixed returns, with precious metals and biotech headwinds limiting gains while a mid-month crude oil reversal undermined small energy plays.

  • GlobeNewswire2 months ago

    CASMED to Report Second-Quarter 2018 Financial Results and Hold Conference Call on August 2

    BRANFORD, Conn., July 27, 2018-- CAS Medical Systems, Inc., a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the second quarter of 2018 ...

  • ACCESSWIRE3 months ago

    Wired News - Halyard Health to Buy CoolSystems; Marketed as Game Ready(R)

    LONDON, UK / ACCESSWIRE / June 7, 2018 / If you want access to our free research report on Halyard Health, Inc. (NYSE: HYH), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HYH as the Company's latest news hit the wire. On June 05, 2018, the Company announced that it has inked a deal to acquire CoolSystems, Inc., marketed as Game Ready®, a market-leading provider of cold therapy and compression therapy systems for a total consideration of $65 million in cash. Active-Investors.com is currently working on the research report for CAS Medical Systems, Inc. (NASDAQ: CASM), which also belongs to the Healthcare sector as the Company Halyard Health.

  • Zacks Small Cap Research4 months ago

    CASM: Q1: FORE-SIGHT Revenue Jumps 20% in Q1. Sensors Sales Accelerating. Moving PT to $4.00/share

    CAS Medical (CASM) reported financial results for Q1 2018. It was an extraordinarily strong showing across their FORE-SIGHT franchise with sensors revenue in both the U.S. and international markets jumping double-digits yoy, pushing total sensors sales almost 10% higher than their prior record (in Q4 ’17). Meanwhile, monitor shipments continue to trend higher - 72 shipped in the U.S., which is the second highest level on-record (80 shipped in Q4 ’17) and 39 OUS, which is the highest since Q4 ’16.

  • Zacks Small Cap Research6 months ago

    CASM: Q4 2017 Financial Results: Record Revenue, Lowest Op Loss. Momentum Expected to Continue

    CAS Medical (CASM) reported financial results for Q4 2017, which saw revenue well ahead of our pre-preliminary announcement numbers (CASM pre-announced Q4 in early January). Strength in the U.S. market, which has been attributed to a combination of catalysts, more than offset a double-digit decline in international sales and pushed total FORE-SIGHT revenue to an all-time high. Indications, which includes 2018 guidance of low-teens percentage increase in U.S. FORE-SIGHT revenue, are that this momentum will continue, and potentially accelerate.

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of CASM earnings conference call or presentation 14-Mar-18 2:00pm GMT

    Q4 2017 CAS Medical Systems Inc Earnings Call

  • What does CAS Medical Systems Inc’s (NASDAQ:CASM) Balance Sheet Tell Us About Its Future?
    Simply Wall St.7 months ago

    What does CAS Medical Systems Inc’s (NASDAQ:CASM) Balance Sheet Tell Us About Its Future?

    CAS Medical Systems Inc (NASDAQ:CASM) is a small-cap stock with a market capitalization of US$31.44M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies,Read More...

  • CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017
    Capital Cube9 months ago

    CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017

    Categories: Yahoo FinanceGet free summary analysis CAS Medical Systems, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of CAS Medical Systems, Inc. – NeuroMetrix, Inc., Utah Medical Products, Inc., Royal Philips NV Sponsored ADR, Masimo Corporation and General Electric Company (NURO-US, UTMD-US, PHG-US, MASI-US and ... Read more (Read more...)

  • Thomson Reuters StreetEvents10 months ago

    Edited Transcript of CASM earnings conference call or presentation 9-Nov-17 3:00pm GMT

    Q3 2017 CAS Medical Systems Inc Earnings Call

  • Zacks Small Cap Research10 months ago

    CASM: Operational Successes Bode Well For Restarting Sensors Sales Growth

    U.S. FORE-SIGHT sales not only returned to growth (+2% yoy and +5% qoq) in Q3, but at $3.8M, set a new record high.  But, with tissue oximetry sales falling by almost 9% yoy and roughly flat sequentially, it was far from a strong quarter as it relates to financial results.  The lack of top-line growth has recently been impacted by softness in China (as that country awaits CFDA approval of FORE-SIGHT ELITE) but remains largely tied to absence of traction in sensor sales, which account for more than 90% of tissue oximetry revenue.  As we have indicated in previous updates, the lack of sensor-related revenue growth in the face of an ever-larger monitor installed base is somewhat anomalistic, in our opinion. As it relates to the sales force, turnover has meant average tenure (and related productivity) decreased – but on the (more recent) positive side, management indicated that overall productivity has improved and sensor-related revenue growth among the more tenured reps has been relatively very strong (which could be a harbinger of maturation-correlated productivity gains among the less tenured).